Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC.
Saved in:
| Title: | Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC. |
|---|---|
| Authors: | Selke, Janne1 (AUTHOR), Dzierma, Yvonne1,2 (AUTHOR), Manda, Katrin1 (AUTHOR), Hildebrandt, Guido1 (AUTHOR), Frerker, Bernd1 (AUTHOR), Kalata, Paul1 (AUTHOR), Ackermann, Christin2 (AUTHOR), Bock, Felix1 (AUTHOR) felix.bock@med.uni-rostock.de |
| Source: | Current Oncology. Jun2026, Vol. 33 Issue 6, p351. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
